Sort
40,608 grants matching “prostate cancer”
Recombinational Mechanisms of DNA Repair
$414,575Wolf-Dietrich Heyer · University Of California At Davis · R01 · FY2025 · GM
Novobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers
$414,529Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Community Outreach and Engagement
$414,494Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2024 · CA
Multimodal MR-PET Machine Learning Approaches for Primary Prostate Cancer Characterization
$414,490Ciprian Catana · Massachusetts General Hospital · R01 · FY2021 · CA
Vitamin D Analogs for Chemoprevention of Prostate Cancer
$414,488Roswell Park Cancer Institute Corp · R01 · FY2005 · CA
Molecular Biology, Regulation, And Biochemistry of UDP-glucuronosyltransferases.
$414,436Ida S Owens · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Statistical Methods for Cancer Biomarkers
$414,412Jeremy Mg Taylor · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Deep learning enabled, deep ultraviolet scanning microscopy for intraoperative assessment of margin status during breast cancer surgery
$414,402Bing Yu · Marquette University · R01 · FY2022 · EB
Molecular Targets for Cancer Detection and Treatment
$414,383Johns Hopkins University · T32 · FY2002 · CA
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$414,368Aasthaa Bansal · University Of Washington · R37 · FY2018 · CA
Suicide Gene and Radiation Therapy Clinical Trials
$414,231Jae Ho Kim · Henry Ford Health System · P01 · FY2008 · CA
Prostate Cancer Recovery Enhancement (PROCARE) for African American Men
$414,230Lisa C Campbell · Duke University · R01 · FY2007 · CA
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
$414,159Paul Trippier · University Of Nebraska Medical Center · R01 · FY2021 · CA
The Radium-223 Combination Therapy Space; Improving Response and Clarifying Toxicities
$414,138Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2024 · CA
ST LOUIS/CAPE GIRARDEAU CCOP
$414,089St. John'S Mercy Medical Center · U10 · FY2000 · CA
Prosaposin: A Novel Biomarker of Prostate Cancer Progression in African Americans
$414,078Shahriar Koochekpour · Roswell Park Cancer Institute Corp · R01 · FY2012 · MD
Prostatitis and Prostate Cancer Development
$414,029Lawrence Fong · University Of California, San Francisco · R01 · FY2016 · CA
Prostatitis and Prostate Cancer Development
$414,029Lawrence Fong · University Of California, San Francisco · R01 · FY2015 · CA
Prostatitis and Prostate Cancer Development
$414,029Lawrence Fong · University Of California, San Francisco · R01 · FY2012 · CA
vivaCT80 - in vivo small animal microCT
$414,000Daniel S Perrien · Vanderbilt University · S10 · FY2014 · OD
Cooperativity of TMPRSS2-ERG fusion with p53 inactivation in prostate cancer pathogenesis
$413,975Liewei Wang · Mayo Clinic Rochester · R01 · FY2025 · CA
PSMAi-PARPi combination agents for the targeted Auger and alpha therapy of metastatic castration-resistant prostate cancer
$413,973Michael Rod Zalutsky · Duke University · R21 · FY2022 · CA
Real-time multiphoton microscopy of periprostatic tissue architecture
$413,932Ashutosh K Tewari · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · EB
Mechanisms of Prostate Cancer Metastasis
$413,864Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Triple Quadrupole (Q-Trap) Mass Spectrometer
$413,850Thomas A Neubert · New York University School Of Medicine · S10 · FY2007 · RR